What does PHARMACIES VISSOUL do?

PHARMACIES VISSOUL is a pharmacy in Thimister-Clermont. Private Limited, started on 20 September 2016, 2 establishments.

What is the address of PHARMACIES VISSOUL?

The registered office of PHARMACIES VISSOUL is located at Centre 32 box A, 4890 Thimister-Clermont.

Is PHARMACIES VISSOUL still active?

Yes. According to the CBE (31 October 2026) PHARMACIES VISSOUL is active, legal situation “Normale toestand”, started on 20 September 2016.

Is PHARMACIES VISSOUL registered on Peppol?

Yes, PHARMACIES VISSOUL is registered on the Peppol network with ID 0208:0662738147.

What is the enterprise number of PHARMACIES VISSOUL?

The enterprise number of PHARMACIES VISSOUL is BE0662738147.

When was PHARMACIES VISSOUL founded?

PHARMACIES VISSOUL was founded on 20 September 2016.

Who are the directors of PHARMACIES VISSOUL?

According to the 2025 annual accounts, the directors of PHARMACIES VISSOUL are: Marie VISSOUL, Cécile VISSOUL.

Is PHARMACIES VISSOUL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 September 2016; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did PHARMACIES VISSOUL make in 2025?

PHARMACIES VISSOUL recorded a loss after taxes of € 78,268 in financial year 2025.

What is the revenue of PHARMACIES VISSOUL?

As a small company, PHARMACIES VISSOUL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 543,531.

How much does an employee at PHARMACIES VISSOUL earn?

The average wage cost per full-time employee at PHARMACIES VISSOUL was € 61,700 in 2025: staff costs of € 327,050 for 5.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIES VISSOUL have?

According to the 2025 annual accounts, PHARMACIES VISSOUL has 5.3 full-time equivalents (FTE).

PHARMACIES VISSOUL (Private Limited) - Thimister-Clermont

Dossier PHARMACIES VISSOUL, printed on 31 October 2026 from databakkes.be/en/0662738147/pharmacies-vissoul. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 48 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIES VISSOUL from Thimister-Clermont, company number BE0662738147, closed financial year 2025 with a result of € -78,268 after tax. For that financial year PHARMACIES VISSOUL recorded a gross margin of € 543,531 and equity of € 126,370. Compared with financial year 2024, the result moved from € -16,882 to € -78,268. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Healthy

€ 126,370

▼ 38% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -78,268

▼ 364 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 108,844

▲ 106% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 107,770.

People and assets in 2025

Full-time equivalents

5.3

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 327,050

▲ 1% vs 2024

€ 61,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 13,744

▲ 102% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 169,252

▼ 43% vs 2024

€ 129,209 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 163,125

▲ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 51,928

▼ 14% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 507,754 Gross margin 2022: € 507,754 First fiscal year in the series	€ 566,933 Gross margin 2023: € 566,933 ▲ 12% vs 2022 (€ 507,754) Favourable step	€ 550,557 Gross margin 2024: € 550,557 ▼ 3% vs 2023 (€ 566,933) Unfavourable step	€ 543,531 Gross margin 2025: € 543,531 ▼ 1% vs 2024 (€ 550,557) Unfavourable step	▼ 1%
Profit after taxes	€ 45,090 Profit after taxes 2022: € 45,090 First fiscal year in the series	€ 59,794 Profit after taxes 2023: € 59,794 ▲ 33% vs 2022 (€ 45,090) Favourable step	€ -16,882 Profit after taxes 2024: € -16,882 ▼ € 76,675 vs 2023 (€ 59,794) Unfavourable step	€ -78,268 Profit after taxes 2025: € -78,268 ▼ € 61,386 vs 2024 (€ -16,882) Unfavourable step	▼ € 61,386
Equity	€ 161,725 Equity 2022: € 161,725 First fiscal year in the series	€ 221,519 Equity 2023: € 221,519 ▲ 37% vs 2022 (€ 161,725) Favourable step	€ 204,637 Equity 2024: € 204,637 ▼ 8% vs 2023 (€ 221,519) Unfavourable step	€ 126,370 Equity 2025: € 126,370 ▼ 38% vs 2024 (€ 204,637) Unfavourable step	▼ 38%
Total debts	€ 897,293 Total debts 2022: € 897,293 First fiscal year in the series	€ 818,506 Total debts 2023: € 818,506 ▼ 9% vs 2022 (€ 897,293) Favourable step	€ 739,804 Total debts 2024: € 739,804 ▼ 10% vs 2023 (€ 818,506) Favourable step	€ 740,798 Total debts 2025: € 740,798 Unchanged (€ 739,804) Unfavourable step
Cash	€ 58,119 Cash 2022: € 58,119 First fiscal year in the series	€ 126,236 Cash 2023: € 126,236 ▲ 117% vs 2022 (€ 58,119) Favourable step	€ 52,826 Cash 2024: € 52,826 ▼ 58% vs 2023 (€ 126,236) Unfavourable step	€ 108,844 Cash 2025: € 108,844 ▲ 106% vs 2024 (€ 52,826) Favourable step	▲ 106%
Retained profit	€ 143,125 Retained profit 2022: € 143,125 First fiscal year in the series	€ 202,919 Retained profit 2023: € 202,919 ▲ 42% vs 2022 (€ 143,125) Favourable step	€ 186,037 Retained profit 2024: € 186,037 ▼ 8% vs 2023 (€ 202,919) Unfavourable step	€ 107,770 Retained profit 2025: € 107,770 ▼ 42% vs 2024 (€ 186,037) Unfavourable step	▼ 42%
Dividend	€ 14,000 Dividend 2022: € 14,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 14,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 552,714 Bank debt 2022: € 552,714 First fiscal year in the series	€ 425,894 Bank debt 2023: € 425,894 ▼ 23% vs 2022 (€ 552,714) Favourable step	€ 298,083 Bank debt 2024: € 298,083 ▼ 30% vs 2023 (€ 425,894) Favourable step	€ 169,252 Bank debt 2025: € 169,252 ▼ 43% vs 2024 (€ 298,083) Favourable step	▼ 43%
Balance sheet total	€ 1,059,018 Balance sheet total 2022: € 1,059,018 First fiscal year in the series	€ 1,040,025 Balance sheet total 2023: € 1,040,025 ▼ 2% vs 2022 (€ 1,059,018) Unchanged	€ 944,442 Balance sheet total 2024: € 944,442 ▼ 9% vs 2023 (€ 1,040,025) Unchanged	€ 867,168 Balance sheet total 2025: € 867,168 ▼ 8% vs 2024 (€ 944,442) Unchanged	▼ 8%
Employees (FTE)	5 Employees (FTE) 2022: 5 First fiscal year in the series	2.7 Employees (FTE) 2023: 2.7 ▼ 2.3 vs 2022 (5) Unchanged	5.3 Employees (FTE) 2024: 5.3 ▲ 2.6 vs 2023 (2.7) Unchanged	5.3 Employees (FTE) 2025: 5.3 Unchanged (5.3) Unchanged

Key figures of PHARMACIES VISSOUL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIES VISSOUL?

What happened at PHARMACIES VISSOUL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: loss of € 78,268. filed late Source: NBB ↗
Jan 1, 2017 New establishment in Thimister-Clermont. KBO
Jan 1, 2017 New establishment in Thimister-Clermont. KBO
Sep 20, 2016 Start of the company according to the CBE. KBO

In short

From € 45,090 profit in 2022 to € 78,268 loss in 2025.

Paid € 41,625 in corporate taxes since 2022.

Best year ever: 2023, with € 59,794 profit.

On average € 102,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Marie VISSOUL Cécile VISSOUL

PHARMACIES VISSOUL

Behind PHARMACIES VISSOUL are Marie VISSOUL and Cécile VISSOUL.

Directors

According to the 2025 annual accounts

Marie VISSOUL

Director

Cécile VISSOUL

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Centre 32 box A

4890 Thimister-Clermont

2.257.468.924

Centre 31 box A

4890 Thimister-Clermont

Active since 1 January 2017

2.257.469.023

route de Battice 40 box B

4890 Thimister-Clermont

Active since 1 January 2017

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0662.738.147
VAT number: BE 0662.738.147
Registered office: Centre 32 bus A, 4890 Thimister-Clermont
Names & denominations: PHARMACIES VISSOUL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 September 2016
Peppol: Active · Active since 24 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIES VISSOUL

Warning lights

Financials

What happened to PHARMACIES VISSOUL?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions